HomeANIX • NASDAQ
add
Anixa Biosciences Inc
Previous close
$3.01
Day range
$3.00 - $3.12
Year range
$2.75 - $5.13
Market cap
97.61M USD
Avg Volume
111.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.61M | 41.20% |
Net income | -3.26M | -40.18% |
Net profit margin | — | — |
Earnings per share | -0.10 | -25.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 23.80M | -14.09% |
Total assets | 25.37M | -10.37% |
Total liabilities | 1.77M | 26.83% |
Total equity | 23.60M | — |
Shares outstanding | 31.90M | — |
Price to book | 3.91 | — |
Return on assets | -35.46% | — |
Return on capital | -38.14% | — |
Cash Flow
Net change in cash
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -3.26M | -40.18% |
Cash from operations | -2.31M | -16.15% |
Cash from investing | 129.00K | 122.05% |
Cash from financing | 2.26M | 75,333.33% |
Net change in cash | 83.00K | 103.23% |
Free cash flow | -1.26M | -3.45% |
About
Founded
1982
Headquarters
Website
Employees
5